Klotho Neurosciences, Inc.

Stock Chart, Company Information, and Scan Results

$0.36(as of Feb 24, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Klotho Neurosciences, Inc. Company Information, Fundamentals, and Technical Indicators

Stock Price$0.36
Ticker SymbolKLTO
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees3
CountyUSA
Market Cap$18.3M

Klotho Neurosciences, Inc. develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates consist of KLTO-101 for the treatment or prevention of Alzheimer's disease; and KLTO-202, a gene therapy product for treatment and prevention of Lou Gehrig's disease. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha, Nebraska.

Klotho Neurosciences, Inc. In Our Stock Scanner

As of Feb 24, 2026
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
As of ---
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.